OmniAb Price To Sales Ratio vs Capex To Operating Cash Flow Analysis

OABI Stock

USD 3.68 0.18 5.14%

OmniAb financial indicator trend analysis is much more than just breaking down OmniAb Inc prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether OmniAb Inc is a good investment. Please check the relationship between OmniAb Price To Sales Ratio and its Capex To Operating Cash Flow accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OmniAb Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

Price To Sales Ratio vs Capex To Operating Cash Flow

Price To Sales Ratio vs Capex To Operating Cash Flow Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of OmniAb Inc Price To Sales Ratio account and Capex To Operating Cash Flow. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between OmniAb's Price To Sales Ratio and Capex To Operating Cash Flow is 0.41. Overlapping area represents the amount of variation of Price To Sales Ratio that can explain the historical movement of Capex To Operating Cash Flow in the same time period over historical financial statements of OmniAb Inc, assuming nothing else is changed. The correlation between historical values of OmniAb's Price To Sales Ratio and Capex To Operating Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Price To Sales Ratio of OmniAb Inc are associated (or correlated) with its Capex To Operating Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capex To Operating Cash Flow has no effect on the direction of Price To Sales Ratio i.e., OmniAb's Price To Sales Ratio and Capex To Operating Cash Flow go up and down completely randomly.

Correlation Coefficient

0.41

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Price To Sales Ratio

Price to Sales Ratio is figured by comparing OmniAb Inc stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on OmniAb sales, a figure that is much harder to manipulate than other OmniAb Inc multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Capex To Operating Cash Flow

Most indicators from OmniAb's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into OmniAb Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OmniAb Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

The current Tax Provision is estimated to decrease to about (4.7 M). The current Selling General Administrative is estimated to decrease to about 20.7 M

	2022	2023	2024	2025 (projected)
Gross Profit	42.8M	34.2M	39.3M	30.4M
Total Revenue	59.1M	34.2M	39.3M	37.3M

Gross Profit Total Revenue

OmniAb fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Accounts Payable	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Net Receivables	Good Will	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Total Liab	Total Current Assets	Intangible Assets	Common Stock	Property Plant Equipment	Current Deferred Revenue	Cash	Cash And Short Term Investments
Total Assets		0.97	0.63	0.95	0.99	-0.77	0.94	0.98	0.13	0.9	0.93	-0.35	0.95	0.28	0.87	-0.82	0.66	0.98	0.89	0.98	-0.72	-0.94	0.95	-0.05	0.88	0.93
Short Long Term Debt Total	0.97		0.52	0.95	0.97	-0.8	0.92	1.0	0.25	0.97	0.87	-0.29	0.9	0.24	0.82	-0.82	0.58	0.96	0.86	0.97	-0.71	-0.91	0.94	0.05	0.8	0.89
Other Current Liab	0.63	0.52		0.68	0.6	-0.09	0.54	0.53	0.19	0.46	0.74	0.05	0.77	0.19	0.75	-0.44	0.55	0.56	0.67	0.54	-0.31	-0.5	0.57	-0.15	0.47	0.55
Total Current Liabilities	0.95	0.95	0.68		0.92	-0.63	0.86	0.96	0.37	0.91	0.93	-0.26	0.94	0.38	0.87	-0.89	0.75	0.93	0.96	0.91	-0.61	-0.84	0.92	0.19	0.73	0.82
Total Stockholder Equity	0.99	0.97	0.6	0.92		-0.81	0.95	0.97	0.07	0.9	0.91	-0.33	0.93	0.19	0.85	-0.76	0.58	0.97	0.84	0.98	-0.76	-0.95	0.94	-0.15	0.9	0.94
Other Liab	-0.77	-0.8	-0.09	-0.63	-0.81		-0.87	-0.8	-0.02	-0.8	-0.65	0.22	-0.67	0.13	-0.62	0.67	-0.27	-0.75	-0.52	-0.79	0.89	0.88	-0.83	0.23	-0.78	-0.86
Net Tangible Assets	0.94	0.92	0.54	0.86	0.95	-0.87		0.92	0.07	0.86	0.87	-0.23	0.94	0.05	0.83	-0.79	0.54	0.91	0.78	0.93	-0.87	-0.99	0.98	-0.22	0.92	1.0
Property Plant And Equipment Net	0.98	1.0	0.53	0.96	0.97	-0.8	0.92		0.21	0.95	0.88	-0.32	0.91	0.27	0.82	-0.82	0.6	0.97	0.87	0.98	-0.7	-0.92	0.94	0.04	0.83	0.89
Net Debt	0.13	0.25	0.19	0.37	0.07	-0.02	0.07	0.21		0.43	0.33	0.55	0.23	-0.02	0.41	-0.47	0.24	0.04	0.34	0.01	-0.17	0.01	0.24	0.55	-0.31	0.0
Accounts Payable	0.9	0.97	0.46	0.91	0.9	-0.8	0.86	0.95	0.43		0.84	-0.07	0.84	0.08	0.83	-0.79	0.45	0.86	0.77	0.88	-0.74	-0.84	0.9	0.06	0.66	0.82
Non Current Assets Total	0.93	0.87	0.74	0.93	0.91	-0.65	0.87	0.88	0.33	0.84		-0.13	0.95	0.21	0.98	-0.87	0.74	0.85	0.91	0.84	-0.74	-0.83	0.92	-0.01	0.73	0.85
Non Currrent Assets Other	-0.35	-0.29	0.05	-0.26	-0.33	0.22	-0.23	-0.32	0.55	-0.07	-0.13		-0.16	-0.77	0.05	0.24	-0.5	-0.5	-0.38	-0.44	-0.12	0.28	-0.19	-0.24	-0.53	-0.23
Other Assets	0.95	0.9	0.77	0.94	0.93	-0.67	0.94	0.91	0.23	0.84	0.95	-0.16		0.19	0.91	-0.84	0.69	0.9	0.9	0.89	-0.74	-0.91	0.96	-0.08	0.82	0.93
Net Receivables	0.28	0.24	0.19	0.38	0.19	0.13	0.05	0.27	-0.02	0.08	0.21	-0.77	0.19		0.06	-0.38	0.73	0.4	0.56	0.29	0.36	-0.04	0.12	0.7	0.2	0.01
Good Will	0.87	0.82	0.75	0.87	0.85	-0.62	0.83	0.82	0.41	0.83	0.98	0.05	0.91	0.06		-0.8	0.63	0.76	0.83	0.76	-0.77	-0.78	0.88	-0.09	0.63	0.81
Common Stock Shares Outstanding	-0.82	-0.82	-0.44	-0.89	-0.76	0.67	-0.79	-0.82	-0.47	-0.79	-0.87	0.24	-0.84	-0.38	-0.8		-0.83	-0.79	-0.92	-0.75	0.66	0.74	-0.89	-0.36	-0.62	-0.74
Non Current Liabilities Total	0.66	0.58	0.55	0.75	0.58	-0.27	0.54	0.6	0.24	0.45	0.74	-0.5	0.69	0.73	0.63	-0.83		0.67	0.9	0.58	-0.26	-0.5	0.64	0.47	0.52	0.5
Other Current Assets	0.98	0.96	0.56	0.93	0.97	-0.75	0.91	0.97	0.04	0.86	0.85	-0.5	0.9	0.4	0.76	-0.79	0.67		0.89	0.99	-0.62	-0.92	0.91	0.02	0.9	0.89
Total Liab	0.89	0.86	0.67	0.96	0.84	-0.52	0.78	0.87	0.34	0.77	0.91	-0.38	0.9	0.56	0.83	-0.92	0.9	0.89		0.83	-0.5	-0.75	0.86	0.32	0.69	0.74
Total Current Assets	0.98	0.97	0.54	0.91	0.98	-0.79	0.93	0.98	0.01	0.88	0.84	-0.44	0.89	0.29	0.76	-0.75	0.58	0.99	0.83		-0.67	-0.94	0.92	-0.07	0.91	0.92
Intangible Assets	-0.72	-0.71	-0.31	-0.61	-0.76	0.89	-0.87	-0.7	-0.17	-0.74	-0.74	-0.12	-0.74	0.36	-0.77	0.66	-0.26	-0.62	-0.5	-0.67		0.85	-0.85	0.39	-0.7	-0.87
Common Stock	-0.94	-0.91	-0.5	-0.84	-0.95	0.88	-0.99	-0.92	0.01	-0.84	-0.83	0.28	-0.91	-0.04	-0.78	0.74	-0.5	-0.92	-0.75	-0.94	0.85		-0.96	0.26	-0.94	-0.99
Property Plant Equipment	0.95	0.94	0.57	0.92	0.94	-0.83	0.98	0.94	0.24	0.9	0.92	-0.19	0.96	0.12	0.88	-0.89	0.64	0.91	0.86	0.92	-0.85	-0.96		-0.06	0.85	0.96
Current Deferred Revenue	-0.05	0.05	-0.15	0.19	-0.15	0.23	-0.22	0.04	0.55	0.06	-0.01	-0.24	-0.08	0.7	-0.09	-0.36	0.47	0.02	0.32	-0.07	0.39	0.26	-0.06		-0.31	-0.3
Cash	0.88	0.8	0.47	0.73	0.9	-0.78	0.92	0.83	-0.31	0.66	0.73	-0.53	0.82	0.2	0.63	-0.62	0.52	0.9	0.69	0.91	-0.7	-0.94	0.85	-0.31		0.93
Cash And Short Term Investments	0.93	0.89	0.55	0.82	0.94	-0.86	1.0	0.89	0.0	0.82	0.85	-0.23	0.93	0.01	0.81	-0.74	0.5	0.89	0.74	0.92	-0.87	-0.99	0.96	-0.3	0.93

Click cells to compare fundamentals

OmniAb Account Relationship Matchups

OmniAb fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	295.4M	304.5M	421.2M	375.2M	431.5M	364.9M
Short Long Term Debt Total	2.6M	13.9M	25.8M	25.6M	29.4M	15.4M
Other Current Liab	12.6M	6.3M	7.8M	8.4M	9.6M	8.9M
Total Current Liabilities	14.3M	20.6M	26.0M	23.1M	26.6M	19.8M
Total Stockholder Equity	235.5M	234.3M	341.4M	314.6M	361.8M	295.7M
Property Plant And Equipment Net	6.0M	20.1M	41.5M	38.1M	43.9M	24.2M
Net Debt	5.2M	27.7M	(7.6M)	9.2M	10.6M	8.1M
Accounts Payable	469K	2.9M	3.0M	4.4M	5.1M	2.5M
Non Current Assets Total	278.7M	281.9M	296.3M	280.3M	322.4M	306.2M
Non Currrent Assets Other	2.1M	1.5M	(18.2M)	2.7M	2.5M	2.6M
Net Receivables	15.9M	21.1M	30.3M	3.8M	4.4M	4.2M
Liabilities And Stockholders Equity	295.4M	304.5M	421.2M	375.2M	431.5M	364.9M
Non Current Liabilities Total	45.6M	49.6M	53.8M	37.5M	43.2M	49.4M
Other Current Assets	774K	1.4M	6.4M	4.1M	4.7M	2.8M
Total Liab	59.8M	70.2M	79.8M	60.6M	69.7M	69.2M
Total Current Assets	16.6M	22.5M	125.0M	94.9M	109.1M	58.7M
Intangible Assets	186.6M	176.3M	167.2M	155.5M	139.9M	137.4M

Currently Active Assets on Macroaxis

BTC	Bitcoin
TRX	TRON
BNB	Binance Coin
ADA	Cardano
XRP	XRP

When determining whether OmniAb Inc is a strong investment it is important to analyze OmniAb's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact OmniAb's future performance. For an informed investment choice regarding OmniAb Stock, refer to the following important reports:

How To Invest In OmniAb

Details

Is OmniAb Stock a good investment?

Details

What is OmniAb's Net Worth?

Details

Largest Business Services Companies

View

Largest Biotechnology Companies

View

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OmniAb Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OmniAb. If investors know OmniAb will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OmniAb listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.62)

Revenue Per Share

0.202

Quarterly Revenue Growth

(0.24)

Return On Assets

(0.14)

Return On Equity

(0.20)

The market value of OmniAb Inc is measured differently than its book value, which is the value of OmniAb that is recorded on the company's balance sheet. Investors also form their own opinion of OmniAb's value that differs from its market value or its book value, called intrinsic value, which is OmniAb's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OmniAb's market value can be influenced by many factors that don't directly affect OmniAb's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between OmniAb's value and its price as these two are different measures arrived at by different means. Investors typically determine if OmniAb is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OmniAb's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

OmniAb Price To Sales Ratio vs Capex To Operating Cash Flow Analysis

Price To Sales Ratio vs Capex To Operating Cash Flow

Price To Sales Ratio vs Capex To Operating Cash Flow Correlation Analysis

Correlation Coefficient

Price To Sales Ratio

Capex To Operating Cash Flow

OmniAb fundamental ratios Correlations

OmniAb Account Relationship Matchups

High Positive Relationship

High Negative Relationship

OmniAb fundamental ratios Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Property Plant And Equipment Net	+ 1.0	Short Long Term Debt Total
Cash And Short Term Investments	+ 1.0	Net Tangible Assets
Total Stockholder Equity	+ 0.99	Total Assets
Total Current Assets	+ 0.99	Other Current Assets
Property Plant And Equipment Net	+ 0.98	Total Assets
Other Current Assets	+ 0.98	Total Assets

Cash And Short Term Investments	- 0.99	Common Stock
Common Stock	- 0.99	Net Tangible Assets
Property Plant Equipment	- 0.96	Common Stock
Common Stock	- 0.95	Total Stockholder Equity
Cash	- 0.94	Common Stock
Common Stock	- 0.94	Total Current Assets